1 terminated, 1 unknown. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Terminated 1, Unknown 1 |
Follow Non-small Cell Lung Cancers: new trials by email Literature Review of Non-small Cell Lung Cancers trials Research Report on Non-small Cell Lung Cancers
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of PRT3789 in Combination With Pembrolizumab in Patients With Advanced or Metastatic Solid Tumors With a SMARCA4 Mutation PRT3789, pembrolizumab - Advanced Solid Tumor, Esophageal Cancer | Phase 2 | Terminated | Prelude Therapeutics Incorporated | 6 | 2025-06-03 | 2026-02-02 |
| Safety of Pentoxifylline and Vitamin E With Stereotactic Ablative Radiotherapy (SABR) in Non-small Cell Lung Cancers stereotactic ablative radiotherapy (SABR), Pentoxifylline - Non-small Cell Lung Cancers | Phase 2 | Unknown | University of Louisville | 59 | 2013-10-01 | 2024-02-07 |
Esophageal Neoplasms (1) · Neoplasm Metastasis (1)
Digestive System Diseases (1) · Digestive System Neoplasms (1) · Esophageal Diseases (1) · Gastrointestinal Diseases (1) · Gastrointestinal Neoplasms (1) · Head and Neck Neoplasms (1) · Neoplasms (1) · Neoplasms by Site (1) · Neoplastic Processes (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1)
Pentoxifylline (1) · pembrolizumab (1)
Prelude Therapeutics Incorporated (1) · University of Louisville (1)
United States (2) · Spain (1)